Login to Your Account

Clinic Roundup

Friday, January 7, 2011
Athersys Inc., of Cleveland, completed patient enrollment of the single-dose arm of a study involving administration of MultiStem to patients being treated for leukemia or other blood-borne cancers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription